Commentary

Issue: Vol. 24 No. 4 (2026): Blood Transfusion 4-2026 (July-August) Publication Date: 2026-06-12
Prehospital whole blood after SWiFT and TOWAR: not superior, not settled: Prehospital whole blood: not superior, not settled

Daniele Prati, Luca Barcella, Chiara Novelli, Irene Cuppari
Issue: Vol. 24 No. 3 (2026): Blood Transfusion 3-2026 (May-June) Publication Date: 2026-02-12
Patient autonomy and Patient Blood Management: lessons from the Pindo Mulla v. Spain Case: PBM and patient autonomy

Antonio Perez-Ferrer, Aryeh Shander, Manuel Muñoz
Issue: Vol. 24 No. 1 (2026): Blood Transfusion 1-2026 (January-February) Publication Date: 2025-10-03
Innovation in Blood Establishment Processes, Strasbourg, 2025: a Conference Report: Conference on Innovation in Blood Establishment Processes

Marie Pflieger, Annika Sepich, Julie Harriague, Margarida Amil, Nigar Ertuğrul Örüç, Tor Audun Hervig, Ína Björg Hjálmarsdóttir, Lene Holm Harritshøj, Luca Mascaretti, Simonetta Pupella, Harald Schennach, Stephen Vardy, Tomislav Vuk, Perrine Arnould, Rada M. Grubovic Rastvorceva, Richard Forde, Marie Emery
Issue: Vol. 23 No. 6 (2025): Blood Transfusion 6-2025 (November-December) Publication Date: 2025-08-04
Artificial Intelligence in transfusion medicine: a paradigm shift on the horizon : AI and transfusion medicine

Fabrice Cognasse, Stéphane Avril, Julia L. Fleck, Hind Hamzeh-Cognasse
Issue: Vol. 23 No. 1 (2025): Blood Transfusion 1-2025 (January-February) Publication Date: 2025-02-14
Fibrinogen: the higher the better? : Fibrinogen: the higher the better?

Anne Godier, Alexandre Mansour, Delphine Garrigue, Sophie Susen
Issue: Vol. 23 No. 1 (2025): Blood Transfusion 1-2025 (January-February) Publication Date: 2025-02-14
Administration of fibrinogen concentrates to patients with severe bleeding. How much is enough? Administration of fibrinogen concentrates favors hemostasis

Santiago R. Leal-Noval, Juan Pedro Martin del Rincón
Issue: Vol. 23 No. 1 (2025): Blood Transfusion 1-2025 (January-February) Publication Date: 2025-01-22
Reversal of oral anticoagulation in emergency conditions: Oral anticoagulant antidotes and reversal modalities

Anna Falanga, Chiara Ambaglio, Luca Barcella
Issue: Vol. 23 No. 1 (2025): Blood Transfusion 1-2025 (January-February) Publication Date: 2025-01-22
Postoperative anemia: prevention without cure is not enough: Postoperative anamia: prevention without cure is not enough

Sandaruwani Abeysiri, Ravishankar Rao Baikady
Issue: Vol. 23 No. 1 (2025): Blood Transfusion 1-2025 (January-February) Publication Date: 2025-01-13
Tranexamic acid in hip fracture repair surgery: safe and effective? TXA & Hip fracture

Sigismond Lasocki, Maëva Campfort, Maxime Léger, Emmanuel Rineau
Issue: Vol. 23 No. 1 (2025): Blood Transfusion 1-2025 (January-February) Publication Date: 2025-01-10
Management of preoperative anemia: iron replacement: Iron replacement in the surgical patient

Caroline Evans, Manuel Muñoz
Issue: Vol. 23 No. 1 (2025): Blood Transfusion 1-2025 (January-February) Publication Date: 2025-01-08
Implementing first pillar of PBM in the Emergency Area: a missed opportunity? Anemia and IV iron in Emergency Area

Ivo Beverina, Carlos Jericó, Manuel Quintana-Díaz
Issue: Vol. 23 No. 1 (2025): Blood Transfusion 1-2025 (January-February) Publication Date: 2025-01-08
Management of postpartum anemia: Management of postpartum anemia

Charlotte Holm, Vanessa Neef, Sue Pavord
Issue: Vol. 23 No. 1 (2025): Blood Transfusion 1-2025 (January-February) Publication Date: 2025-01-07
Direct oral anticoagulants measurement: when is it necessary? DOAC measurement

Armando Tripodi, Marina Marchetti, Erica Scalambrino
Issue: Vol. 23 No. 1 (2025): Blood Transfusion 1-2025 (January-February) Publication Date: 2024-12-19
Managing preoperative anemia: EPO is needed: EPO for preoperative anemia

Emmanuel Rineau, Maëva Campfort, Sigismond Lasocki
Issue: Vol. 23 No. 1 (2025): Blood Transfusion 1-2025 (January-February) Publication Date: 2024-12-12
Inflammation and iron homeostasis – what do blood tests mean? Markers of iron status during inflammation

Giacomo Marchi, Fabiana Busti, Fabio Chesini, Domenico Girelli
Issue: Vol. 23 No. 1 (2025): Blood Transfusion 1-2025 (January-February) Publication Date: 2024-12-06
Patient Blood Management - what is it as a concept? PBM - What is it as a concept?

Joshua Ozawa-Morriello, Sherri Ozawa, Aryeh Shander
Issue: Vol. 23 No. 1 (2025): Blood Transfusion 1-2025 (January-February) Publication Date: 2024-12-03
Coagulation Factor XIII - Last to think about? FXIII - Last to think about?

Tina Tomic Mahecic, Sanja Konosić, Matthias Noitz, Mirna Bobinac
Issue: Vol. 23 No. 3 (2025): Blood Transfusion 3-2025 (May-June) Publication Date: 2024-11-29
Warm autoimmune hemolytic anemia: transfusion lessons and therapeutic perspectives learn from a particular patient: Transfusion and therapeutic perspectives to wAIHA

Jun Yu Woon, Li-Te Chin, Yu-Ting Lee
Issue: Vol. 23 No. 1 (2025): Blood Transfusion 1-2025 (January-February) Publication Date: 2024-11-28
Is there still a role for cell salvage? The role of blood salvage

Jonathan H. Waters
Issue: Vol. 23 No. 1 (2025): Blood Transfusion 1-2025 (January-February) Publication Date: 2024-11-22
Postoperative anemia: is there a role for iron replacement therapy? Postoperative anemia: is there a role for iron replacement therapy?

Elvira Bisbe
Issue: Vol. 23 No. 1 (2025): Blood Transfusion 1-2025 (January-February) Publication Date: 2024-11-22
Restrictive versus liberal transfusion thresholds: lights and shadows: Restrictive vs liberal transfusion

Massimo Franchini, Matteo Zani, Daniele Focosi
Issue: Vol. 23 No. 1 (2025): Blood Transfusion 1-2025 (January-February) Publication Date: 2024-11-22
Which should be the target for preoperative hemoglobin optimization? Hb concentration: is 14 the target?

Daniel Ariza-Villanueva, Donat R. Spahn, Andrés Cobos-Díaz
Issue: Vol. 23 No. 1 (2025): Blood Transfusion 1-2025 (January-February) Publication Date: 2024-11-22
Reticulocyte hemoglobin in the evaluation of erythropoietic activity and iron availability: Reticulocyte Hb; the evaluation of erythropoiesis activity

Eloisa Urrechaga, Mónica Fernández
Issue: Vol. 23 No. 1 (2025): Blood Transfusion 1-2025 (January-February) Publication Date: 2024-11-22
Safety of intraoperative blood salvage in cancer surgery: Blood salvage in cancer surgery

Suma Choorapoikayil, Kai Zacharowski, Patrick Meybohm
Issue: Vol. 23 No. 1 (2025): Blood Transfusion 1-2025 (January-February) Publication Date: 2024-11-22
Anemia is a disease, not a number: Anemia is a disease, not a number

Shane C. Coy, Matthew A. Warner
Issue: Vol. 23 No. 1 (2025): Blood Transfusion 1-2025 (January-February) Publication Date: 2024-11-22
Physiologic transfusion thresholds, better than using Hb-based thresholds? Physiologic transfusion triggers

Matthias Noitz, Martin W. Dünser, Tina Tomić Mahečić, Jens Meier
Issue: Vol. 23 No. 1 (2025): Blood Transfusion 1-2025 (January-February) Publication Date: 2024-11-22
Viscoelastic monitoring of direct oral anticoagulants (DOAC): Viscoeslastic monitoring of DOAC

Lidia Mora, Laura Pons-Pellicé, Manuel Quintana-Díaz
Issue: Vol. 23 No. 1 (2025): Blood Transfusion 1-2025 (January-February) Publication Date: 2024-11-22
PBM and ERAS: mandatory bedfellows : PBM and ERAS

Henrik Kehlet
Issue: Vol. 22 No. 6 (2024): Blood Transfusion 6-2024 (November-December) Publication Date: 2024-09-30
The new SoHO Regulation. What should the blood system expect? New SoHO regulation

Simonetta Pupella
Issue: Vol. 22 No. 6 (2024): Blood Transfusion 6-2024 (November-December) Publication Date: 2024-01-31
Inclusion of cryoprecipitate, pathogen-reduced, in the who model lists of essential medicines for adults and children: a call for action: Cryo-PR in the WHO EML

Jay Epstein, Yuyun Maryuningsih, Jean-Claude Faber, W. Martin Smid, Thierry Burnouf
Issue: Vol. 21 No. 5 (2023): Blood Transfusion 5-2023 (September-October) Publication Date: 2023-03-17
Rituximab in the treatment of immune-mediated thrombotic thrombocytopenic purpura: Rituximab in TTP

Hasan Tahsin Özpolat, Moritz Stolla
Issue: Vol. 21 No. 5 (2023): Blood Transfusion 5-2023 (September-October) Publication Date: 2023-02-24
Prevention and treatment of COVID-19 by mono- and poly-clonal antibodies: mAbs versus pAbs against SARS-CoV-2 variants

David McIntosh, Thierry Burnouf, Michael Karbiener, Maria R. Farcet, Thomas R. Kreil
Issue: Vol. 20 No. 4 (2022): Blood Transfusion - 4 2022 (July-August) Publication Date: 2022-04-19
Protecting blood donor health to meet the patient’s needs

Pierre Tiberghien, Marie Frostin, Jean-Baptiste Thibert, Wolfgang Mayr, Bernardo Rodrigues
Issue: Vol. 20 No. 3 (2022): Blood Transfusion - 3 2022 (May-June) Publication Date: 2022-03-09
Platelet-derived immune-modulatory mediators and transfusion: time to consider their effects?

Fabrice Cognasse, Hind Hamzeh-Cognasse
Issue: Vol. 19 No. 5 (2021): Blood Transfusion - 5 2021 (September-October) Publication Date: 2021-07-20
Black blood matters

Alessandra Berzuini, Barbara Foglieni, Marta Spreafico, Alessandro Gerosa, Nicoletta Revelli, Cinzia Paccapelo, Daniele Prati
Issue: Vol. 19 No. 1 (2021): Blood Transfusion - 1 2021 (January-February) Publication Date: 2020-09-18
Red blood cell morphology in patients with COVID-19-related anaemia

Alessandra Berzuini, Cristiana Bianco, Anna C. Migliorini, Marco Maggioni, Luca Valenti, Daniele Prati
Issue: Vol. 19 No. 1 (2021): Blood Transfusion - 1 2021 (January-February) Publication Date: 2020-09-18
Light and shadows of the new therapies for haemophilia treatment in the Covid-19 era

Samantha Pasca, Ezio Zanon
Issue: Vol. 18 No. 3 (2020): Blood Transfusion - 3 2020 (May-June) Publication Date: 2020-05-07
Blood supply and transfusion support in southern Italy: findings during the first four weeks of the SARS-CoV-2 pandemic

Elvira Grandone, Mario Mastroianno, Antonella Caroli, Angelo Ostuni
Issue: Vol. 18 No. 3 (2020): Blood Transfusion - 3 2020 (May-June) Publication Date: 2020-05-07
COVID-19, thromboembolic risk and thromboprophylaxis: learning lessons from the bedside, awaiting evidence

Antonio Coppola, Maria Lombardi, Maria I. Tassoni, Gaetano Carolla, Maurizio Tala, Rossella Morandini, Oriana Paoletti, Sophie Testa

Submit an Article

Announcements

Winter Closure

The Editorial Office will be closed from December 31 to January 7, 2026.

Season’s greetings to all our readers, authors, and reviewers.

SIMTI 2026

46° Convegno Nazionale di Studi di Medicina Trasfusionale - Abstract Book (in Italian)

SETS 2026

35° Congreso de la Sociedad Española de Transfusión Sanguínea y Terapia Celular - SETS - Abstract Book (in Spanish), is online (https://www.bloodtransfusion.it/bt/issue/view/81).

Madrid, 4-6 June 2026.

Editorial Office Closure Notice

Please note that the BT Editorial Office will be closed until August 26, 2026.

During this period, responses to inquiries and the processing of manuscripts may be delayed. All editorial activities will resume as usual after this date.

Thank you for your understanding.

Best regards,
BT Editorial Office

Impact Factor 2025

We are pleased to announce that Blood Transfusion has achieved a 2025 Impact Factor of 2.7.

PLASTIC RECONSTRUCTIVE AND REGENERATIVE SURGERY

Commentary

Prehospital whole blood after SWiFT and TOWAR: not superior, not settled: Prehospital whole blood: not superior, not settled

Patient autonomy and Patient Blood Management: lessons from the Pindo Mulla v. Spain Case: PBM and patient autonomy

Innovation in Blood Establishment Processes, Strasbourg, 2025: a Conference Report: Conference on Innovation in Blood Establishment Processes

Artificial Intelligence in transfusion medicine: a paradigm shift on the horizon : AI and transfusion medicine

Fibrinogen: the higher the better? : Fibrinogen: the higher the better?

Administration of fibrinogen concentrates to patients with severe bleeding. How much is enough? Administration of fibrinogen concentrates favors hemostasis

Reversal of oral anticoagulation in emergency conditions: Oral anticoagulant antidotes and reversal modalities

Postoperative anemia: prevention without cure is not enough: Postoperative anamia: prevention without cure is not enough

Tranexamic acid in hip fracture repair surgery: safe and effective? TXA & Hip fracture

Management of preoperative anemia: iron replacement: Iron replacement in the surgical patient

Implementing first pillar of PBM in the Emergency Area: a missed opportunity? Anemia and IV iron in Emergency Area

Management of postpartum anemia: Management of postpartum anemia

Direct oral anticoagulants measurement: when is it necessary? DOAC measurement

Managing preoperative anemia: EPO is needed: EPO for preoperative anemia

Inflammation and iron homeostasis – what do blood tests mean? Markers of iron status during inflammation

Patient Blood Management - what is it as a concept? PBM - What is it as a concept?

Coagulation Factor XIII - Last to think about? FXIII - Last to think about?

Warm autoimmune hemolytic anemia: transfusion lessons and therapeutic perspectives learn from a particular patient: Transfusion and therapeutic perspectives to wAIHA

Is there still a role for cell salvage? The role of blood salvage

Postoperative anemia: is there a role for iron replacement therapy? Postoperative anemia: is there a role for iron replacement therapy?

Restrictive versus liberal transfusion thresholds: lights and shadows: Restrictive vs liberal transfusion

Which should be the target for preoperative hemoglobin optimization? Hb concentration: is 14 the target?

Reticulocyte hemoglobin in the evaluation of erythropoietic activity and iron availability: Reticulocyte Hb; the evaluation of erythropoiesis activity

Safety of intraoperative blood salvage in cancer surgery: Blood salvage in cancer surgery

Anemia is a disease, not a number: Anemia is a disease, not a number

Physiologic transfusion thresholds, better than using Hb-based thresholds? Physiologic transfusion triggers

Viscoelastic monitoring of direct oral anticoagulants (DOAC): Viscoeslastic monitoring of DOAC

PBM and ERAS: mandatory bedfellows : PBM and ERAS

The new SoHO Regulation. What should the blood system expect? New SoHO regulation

Inclusion of cryoprecipitate, pathogen-reduced, in the who model lists of essential medicines for adults and children: a call for action: Cryo-PR in the WHO EML

Rituximab in the treatment of immune-mediated thrombotic thrombocytopenic purpura: Rituximab in TTP

Prevention and treatment of COVID-19 by mono- and poly-clonal antibodies: mAbs versus pAbs against SARS-CoV-2 variants

Protecting blood donor health to meet the patient’s needs

Platelet-derived immune-modulatory mediators and transfusion: time to consider their effects?

Black blood matters

Red blood cell morphology in patients with COVID-19-related anaemia

Light and shadows of the new therapies for haemophilia treatment in the Covid-19 era

Blood supply and transfusion support in southern Italy: findings during the first four weeks of the SARS-CoV-2 pandemic

COVID-19, thromboembolic risk and thromboprophylaxis: learning lessons from the bedside, awaiting evidence